On January 30th, the Food and Drug Administration granted U.S. orphan drug designation for ONCONASE(R) for treatment of malignant mesothelioma. The generic name for Onconase(R) is Ranprinase.
Use the following links for orphan products:
- List of Orphan Products Designated January thru February 2007
- Cumulative List of All Orphan Designated Year to Date 2007